|
HESI GTTC ring trial: Concordance between Ames and rodent carcinogenicity outcomes for N-nitrosamines (NAs) with rat and hamster metabolic conditions -Pub
|
|
0
|
135
|
May 13, 2025
|
|
🇪🇺 EMA - Enhanced AMES test conditions
|
|
0
|
826
|
November 15, 2023
|
|
Evidence on the Carcinogenicity of Nitrite in Combination with Amines or Amides
|
|
0
|
560
|
June 6, 2023
|
|
FDA/HESI Collaborative Roadmap: Advancing Hazard and Risk Assessment of Nitrosamine Impurities in Pharmaceuticals
|
|
2
|
963
|
June 5, 2023
|
|
FDA Revisiting the mutagenicity and genotoxicity of N-nitroso propranolol in bacterial and human in vitro assays
|
|
1
|
1652
|
May 24, 2023
|
|
Use of the bacterial reverse mutation assay to predict carcinogenicity of N-nitrosamines -published
|
|
0
|
504
|
September 8, 2022
|